Dorner, Marcus, Joshua Horwitz, Justin Robbins, Walter Barry, Qian Feng, Kathy Mu, Christopher Jones, et al. (2011) 2011. “A Genetically Humanized Mouse Model for Hepatitis C Virus Infection.”. Nature 474 (7350): 208-11. doi:10.1038/nature10168.

Giang, Erick, Marcus Dorner, Jannick Prentoe, Marlène Dreux, Matthew Evans, Jens Bukh, Charles Rice, Alexander Ploss, Dennis Burton, and Mansun Law. (2012) 2012. “Human Broadly Neutralizing Antibodies to the Envelope Glycoprotein Complex of Hepatitis C Virus.”. Proc Natl Acad Sci U S A 109 (16): 6205-10. doi:10.1073/pnas.1114927109.

Shi, Chao, and Alexander Ploss. (2013) 2013. “Hepatitis C Virus Vaccines in the Era of New Direct-Acting Antivirals.”. Expert Rev Gastroenterol Hepatol 7 (2): 171-85. doi:10.1586/egh.12.72.

Stoddard, Mark, Hui Li, Shuyi Wang, Mohsan Saeed, Linda Andrus, Wenge Ding, Xinpei Jiang, et al. (2015) 2015. “Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted Founder Genotypes 1, 3, and 4.”. MBio 6 (2): e02518. doi:10.1128/mBio.02518-14.

Jong, Ype, Marcus Dorner, Michiel Mommersteeg, Jing Xiao, Alejandro Balazs, Justin Robbins, Benjamin Winer, et al. (2014) 2014. “Broadly Neutralizing Antibodies Abrogate Established Hepatitis C Virus Infection.”. Sci Transl Med 6 (254): 254ra129. doi:10.1126/scitranslmed.3009512.

Perin, Paula, Sibylle Haid, Richard Brown, Juliane Doerrbecker, Kai Schulze, Carsten Zeilinger, Markus Schaewen, et al. (2016) 2016. “Flunarizine Prevents Hepatitis C Virus Membrane Fusion in a Genotype-Dependent Manner by Targeting the Potential Fusion Peptide Within E1.”. Hepatology 63 (1): 49-62. doi:10.1002/hep.28111.